SII seeks permission for phase-Three learn about of Covid vaccine Covovax as booster dose in adults
Serum Institute of India has sought permission from India’s drug regulator to habits a phase-Three learn about of its COVID-19
Read MoreSerum Institute of India has sought permission from India’s drug regulator to habits a phase-Three learn about of its COVID-19
Read MoreSerum Institute of India (SII) has recommended the federal government to fast-track Covishield motion bringing up the difficulties being confronted
Read MoreThe federal government has accredited Serum Institute of India (SII) to export 10 lakh Covishield doses every to Nepal, Myanmar
Read MoreKnowledgeable panel of India’s Central Drug Authority on Tuesday beneficial granting permission to Serum Institute of India (SII) for carrying
Read MoreSerum Institute of India’s CEO Adar Poonawalla gets ‘Y’ class safety throughout India via the CRPF, the Union executive officers
Read MoreSerum Institute Of India will provide 1.1 billion doses of COVID-19 vaccines for WHO’s scheme. Geneva/London: Serum Institute Of India
Read MoreNanded-based company Cutis-Biotech has filed a case towards Serum Institute of India. Pune: A civil courtroom in Pune on Tuesday
Read MoreBy way of: ENS Financial Bureau | New Delhi | Up to date: November 13, 2020 12:32:45 am The pains
Read More